In this issue:
Efficacy of lurasidone in the treatment of agitation
Cancer mortality in patients with schizophrenia
Sustainability of treatment effect of a 3-year early intervention programme for first-episode psychosis
Efficacy and safety of low-dose olanzapine plus low-dose trifluoperazine vs full-dose olanzapine in the acute treatment of schizophrenia
Intranasal oxytocin for social cognitive deficits in people with schizophrenia
Cognitive remediation and occupational outcome in schizophrenia
Predictors of favourable outcome in first episode psychosis patients without antipsychotic medication
Real-world effectiveness of antipsychotic treatments in a nationwide cohort of patients with schizophrenia
Effect of liraglutide treatment on prediabetes and weight in clozapine or olanzapine treated patients with schizophrenia
Effect of substance use on 10-year outcome in first-episode psychosis
Please login below to download this issue (PDF)